Prenatal vitamin D for schizophrenia

The genetic and environmental factors behind schizophrenia are poorly understood, but research is increasingly finding links between maternal vitamin D status and the risk...

First 100,000 Australians receive COVID-19 vaccines

More than 100,000 Australians have received their first COVID-19 vaccination, and the country now has 1.3 million doses on hand for the next rollout phases.

The pain of uncertainty: Managing pain without codeine

With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...

Overprescribing of psychotropics for adults with autism

Adults on the autism spectrum are often prescribed psychotropic medication to manage behaviour, despite limited evidence to support this practice, a new report has...

From the President: PSA at the FIP World Congress in Seville,...

I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...

Government commits $25m to medicine safety research

The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.